National Lung Screening Trial Research T. Lung cancer incidence and mortality with extended follow-up in the national lung screening trial. J Thorac Oncol. 2019;14(10):1732–42.

Article  Google Scholar 

Sharma R. Mapping of global, regional and national incidence, mortality and mortality-to-incidence ratio of lung cancer in 2020 and 2050. Int J Clin Oncol. 2022;27(4):665–75.

Article  PubMed  PubMed Central  Google Scholar 

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018. https://doi.org/10.3322/caac.21492.

Article  PubMed  Google Scholar 

International Early Lung Cancer Action Program I, Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS. Survival of patients with stage I lung cancer detected on CT screening. New Engl J Med. 2006;355(17):1763–71.

Article  Google Scholar 

National Lung Screening Trial Research T, Church TR, Black WC, Aberle DR, Berg CD, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gierada DS, et al. Results of initial low-dose computed tomographic screening for lung cancer. New Engl J Med. 2013;368(21):1980–91.

Article  Google Scholar 

Infante M, Cavuto S, Lutman FR, Passera E, Chiarenza M, Chiesa G, Brambilla G, Angeli E, Aranzulla G, Chiti A, et al. Long-term follow-up results of the DANTE trial, a randomized study of lung cancer screening with spiral computed tomography. Am J Respir Crit Care Med. 2015;191(10):1166–75.

Article  PubMed  Google Scholar 

Hoffman RM, Atallah RP, Struble RD, Badgett RG. Lung cancer screening with low-dose CT: a meta-analysis. J Gen Intern Med. 2020;35(10):3015–25.

Article  PubMed  PubMed Central  Google Scholar 

Coughlin JM, Zang Y, Terranella S, Alex G, Karush J, Geissen N, Chmielewski GW, Arndt AT, Liptay MJ, Zimmermann LJ, et al. Understanding barriers to lung cancer screening in primary care. J Thorac Dis. 2020;12(5):2536–44.

Article  PubMed  PubMed Central  Google Scholar 

Xie H, Chen J, Lv X, Zhang L, Wu J, Ge X, Yang Q, Zhang D, Chen J. Clinical value of serum and exhaled breath condensate miR-186 and IL-1beta levels in non-small cell lung cancer. Technol Cancer Res Treat. 2020;19:1533033820947490.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen JL, Han HN, Lv XD, Ma H, Wu JN, Chen JR. Clinical value of exhaled breath condensate let-7 in non-small cell lung cancer. Int J Clin Exp Pathol. 2020;13(2):163–71.

PubMed  PubMed Central  Google Scholar 

Stachowiak Z, Wojsyk-Banaszak I, Jonczyk-Potoczna K, Narozna B, Langwinski W, Kycler Z, Sobkowiak P, Breborowicz A, Szczepankiewicz A. MiRNA expression profile in the airways is altered during pulmonary exacerbation in children with cystic fibrosis-a preliminary report. J Clin Med. 2020;9(6):1887.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sabeti Z, Ansarin A, Ansarin K, Zafari V, Seyedrezazadeh E, Shakerkhatibi M, Asghari-Jafarabadi M, Dastgiri S, Zoroufchi Benis K, Sepehri M, et al. Sex-specific association of exposure to air pollutants and Nrf2 gene expression and inflammatory biomarkers in exhaled breath of healthy adolescents. Environ Pollut. 2023;326: 121463.

Article  CAS  PubMed  Google Scholar 

Tiplamaz S, Eyuboglu IP, Unal C, Soyer O, Beksac MS, Akkiprik M. Presence of fetal DNA in maternal exhaled breath condensate. Prenat Diagn. 2023;43(1):28–35.

Article  CAS  PubMed  Google Scholar 

Bikov A, Pako J, Montvai D, Kovacs D, Koller Z, Losonczy G, Horvath I. Exhaled breath condensate pH decreases following oral glucose tolerance test. J Breath Res. 2015;9(4): 047112.

Article  PubMed  Google Scholar 

Bikov A, Lazar Z, Gyulai N, Szentkereszty M, Losonczy G, Horvath I, Galffy G. Exhaled breath condensate pH in lung cancer, the impact of clinical factors. Lung. 2015;193(6):957–63.

Article  CAS  PubMed  Google Scholar 

Mehta A, Cordero J, Dobersch S, Romero-Olmedo AJ, Savai R, Bodner J, Chao CM, Fink L, Guzman-Diaz E, Singh I, et al. Non-invasive lung cancer diagnosis by detection of GATA6 and NKX2-1 isoforms in exhaled breath condensate. EMBO Mol Med. 2016;8(12):1380–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dobersch S, Rubio K, Barreto G. Pioneer factors and architectural proteins mediating embryonic expression signatures in cancer. Trends Mol Med. 2019. https://doi.org/10.1016/j.molmed.2019.01.008.

Article  PubMed  Google Scholar 

Singh I, Mehta A, Contreras A, Boettger T, Carraro G, Wheeler M, Cabrera-Fuentes HA, Bellusci S, Seeger W, Braun T, et al. Hmga2 is required for canonical WNT signaling during lung development. BMC Biol. 2014;12:21.

Article  PubMed  PubMed Central  Google Scholar 

Orstad G, Fort G, Parnell TJ, Jones A, Stubben C, Lohman B, Gillis KL, Orellana W, Tariq R, Klingbeil O, et al. FoxA1 and FoxA2 control growth and cellular identity in NKX2–1-positive lung adenocarcinoma. Dev Cell. 2022;57(15):1866-1882 e1810.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arnal-Estape A, Cai WL, Albert AE, Zhao M, Stevens LE, Lopez-Giraldez F, Patel KD, Tyagi S, Schmitt EM, Westbrook TF, et al. Tumor progression and chromatin landscape of lung cancer are regulated by the lineage factor GATA6. Oncogene. 2020;39(18):3726–37.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li H, Feng C, Shi S. miR-196b promotes lung cancer cell migration and invasion through the targeting of GATA6. Oncol Lett. 2018;16(1):247–52.

PubMed  PubMed Central  Google Scholar 

Gong C, Fan Y, Zhou X, Lai S, Wang L, Liu J. Comprehensive analysis of expression and prognostic value of GATAs in lung cancer. J Cancer. 2021;12(13):3862–76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Otalora-Otalora BA, Osuna-Garzon DA, Carvajal-Parra MS, Canas A, Montecino M, Lopez-Kleine L, Rojas A. Identifying general tumor and specific lung cancer biomarkers by transcriptomic analysis. Biology. 2022;11(7):1082.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rubio K, Romero-Olmedo AJ, Sarvari P, Swaminathan G, Ranvir VP, Rogel-Ayala DG, Cordero J, Gunther S, Mehta A, Bassaly B, et al. Non-canonical integrin signaling activates EGFR and RAS-MAPK-ERK signaling in small cell lung cancer. Theranostics. 2023;13(8):2384–407.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dobersch S, Rubio K, Singh I, Gunther S, Graumann J, Cordero J, Castillo-Negrete R, Huynh MB, Mehta A, Braubach P, et al. Positioning of nucleosomes containing gamma-H2AX precedes active DNA demethylation and transcription initiation. Nat Commun. 2021;12(1):1072.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nicholson AG, Chansky K, Crowley J, Beyruti R, Kubota K, Turrisi A, Eberhardt WE, van Meerbeeck J, Rami-Porta R, Staging, et al. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: proposals for the revision of the clinical and pathologic staging of small cell lung cancer in the forthcoming eighth edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11(3):300–11.

Article  PubMed  Google Scholar 

Horvath I, Hunt J, Barnes PJ, Alving K, Antczak A, Baraldi E, Becher G, van Beurden WJ, Corradi M, Dekhuijzen R, et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J. 2005;26(3):523–48.

Article  CAS  PubMed  Google Scholar 

Horvath I, Barnes PJ, Loukides S, Sterk PJ, Hogman M, Olin AC, Amann A, Antus B, Baraldi E, Bikov A, et al. A European Respiratory Society technical standard: exhaled biomarkers in lung disease. Eur Respiratory J. 2017;49(4):1600965.

Article  Google Scholar 

Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307–10.

Article  CAS  PubMed  Google Scholar 

Sing T, Sander O, Beerenwinkel N, Lengauer T. ROCR: visualizing classifier performance in R. Bioinformatics. 2005;21(20):3940–1.

Article  CAS  PubMed  Google Scholar 

Tetik Vardarli A, Ozgur S, Goksel T, Korba K, Karakus HS, Asik A, Pelit L, Gunduz C. Conversion of specific lncRNAs to biomarkers in exhaled breath condensate samples of patients with advanced stage non-small-cell lung cancer. Front Genet. 2023;14:1200262.

Article  PubMed  PubMed Central  Google Scholar 

Shi M, Han W, Loudig O, Shah CD, Dobkin JB, Keller S, Sadoughi A, Zhu C, Siegel RE, Fernandez MK, et al. Initial development and testing of an exhaled microRNA detection strategy for lung cancer case-control discrimination. Sci Rep. 2023;13(1):6620.

Article  CAS  PubMed  PubMed Central  Google Scholar